These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16235042)

  • 1. How do psychiatrists choose among different antipsychotics?
    Hamann J; Kolbe G; Cohen R; Leucht S; Kissling W
    Eur J Clin Pharmacol; 2005 Dec; 61(11):851-4. PubMed ID: 16235042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
    Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
    Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Genotype Information on Psychiatrists' Treatment Recommendations: More Experienced Clinicians Know Better What to Ignore.
    McMichael AJ; Boeri M; Rolison JJ; Kane J; O'Neill FA; Scarpa R; Kee F
    Value Health; 2017 Jan; 20(1):126-131. PubMed ID: 28212953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
    Patel MX; Nikolaou V; David AS
    Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in clinical practice. The refractory schizophrenic patients treatment].
    Meder J; Tyszkowska M; Jarema M; Araszkiewicz A; Szafrański T
    Psychiatr Pol; 2008; 42(6):859-73. PubMed ID: 19441664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of Croatian psychiatrists towards long-acting injectable antipsychotics.
    Ciglar M; Bjedov S; Maleković H
    Psychiatr Danub; 2016 Sep; 28(3):273-277. PubMed ID: 27658836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antipsychotics in clinical practice. Treatment of the first schizophrenic episode].
    Jarema M; Meder J; Araszkiewicz A; Tyszkowska M
    Psychiatr Pol; 2008; 42(6):841-58. PubMed ID: 19441663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatrists' perspectives on antipsychotic dose and the role of plasma concentration therapeutic drug monitoring.
    Best-Shaw L; Gudbrandsen M; Nagar J; Rose D; David AS; Patel MX
    Ther Drug Monit; 2014 Aug; 36(4):486-93. PubMed ID: 24384695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription.
    Ito H; Koyama A; Higuchi T
    Br J Psychiatry; 2005 Sep; 187():243-7. PubMed ID: 16135861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric decision making in the adoption of a new antipsychotic in Germany.
    Hamann J; Adjan S; Leucht S; Kissling W
    Psychiatr Serv; 2006 May; 57(5):700-3. PubMed ID: 16675766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of psychiatrists toward antipsychotic depot medication.
    Heres S; Hamann J; Kissling W; Leucht S
    J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatrists' psychotropic drug prescription preferences for themselves or their family members.
    Latas M; Stojkovic T; Ralic T; Milovanovic S; Jasovic-Gasic M
    Psychiatr Danub; 2012 Jun; 24(2):182-7. PubMed ID: 22706417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatrists' Attitude and Use of Second-generation Antipsychotics for the Treatment of Schizophrenia in Taiwan.
    Chen CK; Su HH; Sun IW
    East Asian Arch Psychiatry; 2017 Sep; 27(3):91-6. PubMed ID: 28993541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia.
    Sugawara N; Yasui-Furukori N; Yamazaki M; Shimoda K; Mori T; Sugai T; Suzuki Y; Someya T
    PLoS One; 2014; 9(1):e86826. PubMed ID: 24466260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.
    Heres S; Reichhart T; Hamann J; Mendel R; Leucht S; Kissling W
    Eur Psychiatry; 2011; 26(5):297-301. PubMed ID: 20570493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.
    Kulkarni J; Reeve-Parker K
    Australas Psychiatry; 2015 Jun; 23(3):258-64. PubMed ID: 25783668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.